WHAT WE DO

Banked organoids

Commercially Available PDOs

PDOs grown at scale using our proprietary bioprocess, commercially available off-the-shelf.

Bespoke development

Fee-for-Service Development and Manufacturing

Bespoke ‘Fee-for-Service’ development and scaled manufacturing of any (compatible) PDO lines.

Patient Derived Organoid

Enablement of PDO Technology

Full pipeline support for the enablement of PDO technology, from sourcing, line development, technology access, QMS and know-how.

NEWS

organoid culture
Cellesce Patent Granted
Vicky Marsh-Durban
Vicky Marsh Durban Appointed CEO
Tim Watts
Cellesce Strengthens Board of Directors

WHY CELLESCE?

Cellesce’s research and development continues at pace encompassing these main business drivers:
Scale-up and bioprocessing
Expand organoid tissue types and lines
Morphometry
Immuno-oncology
Cellesce continues to build relationships within the organoid ecosystem to enable this patient centric technology and to drive forward PDO utilisation earlier in R&D.

OUR PARTNERS